By proceeding, you agree to our Terms of Use and Privacy Policy.
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.
15-19 May 2023
The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth prese
Event Ended
Hybrid
Paid
Boston
07-08 August 2023
Great progress has been made in studying cancer immunology and the development of immunotherapies. The complexity of the immune system and the duplicity of cancer, plus the expense of treatments and variable patient responses, make for a perfect data
USA
Cell therapies such as CAR Ts are now a proven treatment approach for hematological cancers, but challenges remain around CAR T’s ability to target solid tumors. Cambridge Healthtech Institute’s Tenth Annual Advances in CAR T Therapy conference bring
Bispecific antibodies are generating increased excitement for their potential to effectively target complex diseases through a dual-engagement approach. There are many new and powerful breakthroughs with bispecific antibodies relating to fine tuning
07-09 August 2023
Over the past 11 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the next wave of biotherapeutics, advances in technologies, and the valuable exchange of high-quality research from all disciplines of immuno-oncol
08-09 August 2023
Advances in harnessing the immune system for therapeutic development have resulted in a robust pipeline of immuno-oncology therapies and novel combinations. A successful program requires appropriate models and tools for preclinical evaluation and eff
Up until now, the cell therapy industry has been driven by the remarkable success of CAR T therapy. However, many believe the future of immunotherapy lies with other cell types such as NKs, Gamma Deltas, B Cells, TILs, and B cells, which offer many a
In recent years, Immunotherapy has been at the forefront of oncology research. However, this has not been without issues. Some of which include applications to solid tumors, regulating biodistribution, and serious side effects. During this conference
13-14 September 2023
BioPharm America 2023 is the premier event where the next generation of life science innovators converge to shape the future of drug development. With a focus on collaboration and partnership, this conference brings together hundreds of visionary lea
Raleigh
25-28 September 2023
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.
02-04 October 2023
Join us for the 14th World Bispecific Summit in 2023, where we celebrate the remarkable advancements and immense potential of bispecific antibody treatments. In this pivotal year, bispecific antibody therapies have emerged as formidable contenders in
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea
San Diego